ย้ถนดซรฝ

MedpageToday

Current Advances in the Management of Nonurothelial Subtypes of Bladder Cancer

โ€“ An ASCO Reading Room selection


This Reading Room is a collaboration between ย้ถนดซรฝยฎ and:

Medpage Today
Below is the abstract of the article. or on the link below.

Urothelial cancer (UC) is the most common histology seen in bladder tumors. The 2022 WHO classification of urinary tract tumors includes a list of less common subtypes (formerly known as variants) for invasive UC which are considered high-grade tumors.

This review summarizes the most recent advances in the management of selected nonurothelial subtypes of bladder cancer: squamous cell carcinoma, small cell carcinoma, sarcomatoid urothelial carcinoma, micropapillary carcinoma, plasmacytoid carcinoma, adenocarcinoma, and urachal carcinoma.

The role of neoadjuvant and adjuvant chemotherapy has not been well characterized for most of these histologies, and prospective data are extremely limited. Participation in clinical trials is recommended in advanced disease.

Read an interview about the review here.

Read the full article

Current Advances in the Management of Nonurothelial Subtypes of Bladder Cancer

Primary Source

ASCO Educational Book

Source Reference:

ASCO Publications Corner

ASCO Publications Corner